Andreas Puschmann, Fabienne C. Fiesel, Thomas R. Caulfield, Roman Hudec, Maya Ando, Dominika Truban, Xu Hou, Kotaro Ogaki, Michael G. Heckman, Elle D. James, Maria Swanberg, Itzia Jimenez-Ferrer, Oskar Hansson, Grzegorz Opala, Joanna Siuda, Magdalena Boczarska-Jedynak, Andrzej Friedman, Dariusz Koziorowski, Monika Rudzińska-Bar jan, O. Aasly, Timothy Lynch, George D. Mellick, Megha Mohan, Peter A. Silburn, Yanosh Sanotsky, Carles Vilariño-Güell, Matthew J. Farrer, Li Chen, Valina L. Dawson, Ted M. Dawson, Zbigniew K. Wszolek, Owen A. Ross, Wolfdieter Springer. Heterozygous PINK1 p.G411S increases risk of Parkinson's disease via a dominant-negative mechanism. Brain 2017; 140: 98117; 10.1093/brain/aww261.
The authors apologize for an error in in the author list and author affiliations, which should read as follows:
Andreas Puschmann,1,2,* Fabienne C. Fiesel,3,* Thomas R. Caulfield,3,* Roman Hudec,3,* Maya Ando,3,* Dominika Truban,3 Xu Hou,3 Kotaro Ogaki,3 Michael G. Heckman,4 Elle D. James,3 Maria Swanberg,5 Itzia Jimenez-Ferrer,5 Oskar Hansson,6,7 Grzegorz Opala,8 Joanna Siuda,8 Magdalena Boczarska-Jedynak,8 Andrzej Friedman,9 Dariusz Koziorowski,9 Monika Rudzińska-Bar,8 Jan O. Aasly,10 Timothy Lynch,11 George D. Mellick,12 Megha Mohan,12 Peter A. Silburn,12,13 Yanosh Sanotsky,14 Carles Vilariño-Güell,3,15 Matthew J. Farrer,3,15 Li Chen,16,17,18 Valina L. Dawson,16,17,18,19,20 Ted M. Dawson,16,17,18,19,21 Zbigniew K. Wszolek,22 Owen A. Ross,3,23,24,* and Wolfdieter Springer3,24,*
*These authors contributed equally to this work.
1 Lund University, Department of Clinical Sciences Lund, Neurology, Sweden
2 Department of Neurology, Skåne University Hospital, Sweden
3 Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
4 Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, FL 32224, USA
5 Lund University, Department of Experimental Medical Science, Lund, Sweden
6 Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Sweden
7 Memory Clinic, Skåne University Hospital, Malmö, Sweden
8 Department of Neurology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
9 Department of Neurology, Medical University of Warsaw, Poland
10 Department of Neurology, St. Olav’s Hospital, and Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway
11 Dublin Neurological Institute at the Mater Misericordiae University Hospital, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland
12 Eskitis Institute for Drug Discovery, Griffith University, Nathan, Queensland, Australia
13 University of Queensland, Asia-Pacific Centre for Neuromodulation, Centre for Clinical Research, Brisbane, Queensland, Australia
14 Lviv Regional Clinical Hospital, Lviv, Ukraine
15 Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
16 Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
17 Solomon H Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
18 Adrienne Helis Malvin Medical Research Foundation, New Orleans, LA 70130-2685, USA
19 Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
20 Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
21 Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
22 Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA
23 School of Medicine and Medical Science, University College Dublin, Dublin, Ireland
24 Mayo Graduate School, Neurobiology of Disease, Mayo Clinic, Jacksonville, FL 32224, USA